These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 10330423)

  • 61. Functional importance of estrogen receptors in the periodontium.
    Nebel D
    Swed Dent J Suppl; 2012; (221):11-66. PubMed ID: 22479908
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Autocrine regulation of collagenase 3 (matrix metalloproteinase 13) during osteoarthritis.
    Shlopov BV; Gumanovskaya ML; Hasty KA
    Arthritis Rheum; 2000 Jan; 43(1):195-205. PubMed ID: 10643716
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Suppression of ligand-dependent estrogen receptor activity by bone-resorbing cytokines in human osteoblasts.
    Bodine PV; Harris HA; Komm BS
    Endocrinology; 1999 Jun; 140(6):2439-51. PubMed ID: 10342828
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Siglec-15 is a potential therapeutic target for postmenopausal osteoporosis.
    Kameda Y; Takahata M; Mikuni S; Shimizu T; Hamano H; Angata T; Hatakeyama S; Kinjo M; Iwasaki N
    Bone; 2015 Feb; 71():217-26. PubMed ID: 25460183
    [TBL] [Abstract][Full Text] [Related]  

  • 65. T-cells mediate an inhibitory effect of interleukin-4 on osteoclastogenesis.
    Mirosavljevic D; Quinn JM; Elliott J; Horwood NJ; Martin TJ; Gillespie MT
    J Bone Miner Res; 2003 Jun; 18(6):984-93. PubMed ID: 12817750
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Human microvascular endothelial cell activation by IL-1 and TNF-alpha stimulates the adhesion and transendothelial migration of circulating human CD14+ monocytes that develop with RANKL into functional osteoclasts.
    Kindle L; Rothe L; Kriss M; Osdoby P; Collin-Osdoby P
    J Bone Miner Res; 2006 Feb; 21(2):193-206. PubMed ID: 16418775
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Fluorosis increases the risk of postmenopausal osteoporosis by stimulating interferon γ.
    Lv YG; Kang L; Wu G
    Biochem Biophys Res Commun; 2016 Oct; 479(2):372-379. PubMed ID: 27644876
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor.
    Bellido T; Jilka RL; Boyce BF; Girasole G; Broxmeyer H; Dalrymple SA; Murray R; Manolagas SC
    J Clin Invest; 1995 Jun; 95(6):2886-95. PubMed ID: 7769130
    [TBL] [Abstract][Full Text] [Related]  

  • 69. IL-1 beta scavenging by the type II IL-1 decoy receptor in human neutrophils.
    Bourke E; Cassetti A; Villa A; Fadlon E; Colotta F; Mantovani A
    J Immunol; 2003 Jun; 170(12):5999-6005. PubMed ID: 12794127
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Estrogen deficiency increases the ability of stromal cells to support murine osteoclastogenesis via an interleukin-1and tumor necrosis factor-mediated stimulation of macrophage colony-stimulating factor production.
    Kimble RB; Srivastava S; Ross FP; Matayoshi A; Pacifici R
    J Biol Chem; 1996 Nov; 271(46):28890-7. PubMed ID: 8910536
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cytokines and T-lymphocyte subsets in healthy post-menopausal women: estrogen retards bone loss without affecting the release of IL-1 or IL-1ra.
    Abrahamsen B; Bendtzen K; Beck-Nielsen H
    Bone; 1997 Mar; 20(3):251-8. PubMed ID: 9071476
    [TBL] [Abstract][Full Text] [Related]  

  • 72. IL-1β promotes osteoclastogenesis by increasing the expression of IGF2 and chemokines in non-osteoclastic cells.
    Otsuka Y; Kondo T; Aoki H; Goto Y; Kawaguchi Y; Waguri-Nagaya Y; Miyazawa K; Goto S; Aoyama M
    J Pharmacol Sci; 2023 Jan; 151(1):1-8. PubMed ID: 36522118
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Interleukin-1 receptor accessory protein interacts with the type II interleukin-1 receptor.
    Malinowsky D; Lundkvist J; Layé S; Bartfai T
    FEBS Lett; 1998 Jun; 429(3):299-302. PubMed ID: 9662436
    [TBL] [Abstract][Full Text] [Related]  

  • 74. IL-1 signaling cascade in liver cells and the involvement of a soluble form of the IL-1 receptor accessory protein.
    Jensen LE; Muzio M; Mantovani A; Whitehead AS
    J Immunol; 2000 May; 164(10):5277-86. PubMed ID: 10799889
    [TBL] [Abstract][Full Text] [Related]  

  • 75. New insights into the cellular, biochemical, and molecular basis of postmenopausal and senile osteoporosis: roles of IL-6 and gp130.
    Manolagas SC; Bellido T; Jilka RL
    Int J Immunopharmacol; 1995 Feb; 17(2):109-16. PubMed ID: 7657404
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Abnormal interleukin-1 receptor type II gene expression in the endometrium of women with endometriosis.
    Kharfi A; Boucher A; Akoum A
    Biol Reprod; 2002 Feb; 66(2):401-6. PubMed ID: 11804955
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Human giant cell tumors of the bone (osteoclastomas) are estrogen target cells.
    Oursler MJ; Pederson L; Fitzpatrick L; Riggs BL; Spelsberg T
    Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5227-31. PubMed ID: 8202473
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Dexamethasone up-regulates type II IL-1 receptor in mouse primary activated astrocytes.
    Pousset F; Cremona S; Dantzer R; Kelley KW; Parnet P
    J Neurochem; 2001 Feb; 76(3):901-9. PubMed ID: 11158262
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts.
    Kameda T; Mano H; Yuasa T; Mori Y; Miyazawa K; Shiokawa M; Nakamaru Y; Hiroi E; Hiura K; Kameda A; Yang NN; Hakeda Y; Kumegawa M
    J Exp Med; 1997 Aug; 186(4):489-95. PubMed ID: 9254647
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effects of dexamethasone treatment on IL-1 receptor mRNA levels in vivo.
    Yu PW; Schuler LA; Kehrli M; Mattocks L; Nonnecke BJ; Czuprynski CJ
    J Leukoc Biol; 1997 Sep; 62(3):401-4. PubMed ID: 9307081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.